An increasingly important focus of aging and dementia research is the earliest departure from normal cognition into cognitive decline among cognitively healthy elderly individuals. A variety of recent research
1-5 has suggested that macroscopic structural changes in the brain, which are identifiable through magnetic resonance imaging (MRI), may be discernible years before measurable cognitive loss. These MRI markers of incipient cognitive decline among healthy elderly individuals have become especially important for both clarifying the biological underpinnings of dementia and clinically identifying healthy individuals at high risk of cognitive decline. Recognizing that neurodegenerative diseases such as Alzheimer disease (AD) will be most effectively prevented or slowed when treated early, identifying such cases of increased risk using widely available procedures such as brain MRI is becoming increasingly vital.